Compensation: 20–25% Uncapped Commission + Advisory Equity

Structure: Commission-Only Partner (Independent Contractor)

The Opportunity: Sell "Alpha," Not Software

We are floatz . We use AI to stress-test the science behind biotech deals. Our tech predicted the Rubius Therapeutics collapse ($200M+ loss) 2 years early.

We are seeking a Strategic Sales Partner to bridge the gap between our engine and the Buy-Side.

You aren't a rep; you are a channel owner. You leverage your existing trust with Portfolio Managers to sell "Drawdown Protection" (Scientific Risk Audits). You provide the access; we provide the "Soft Dollar" (Section 28e) product that closes in <3 weeks.

Who You Are (The "Must Haves") You are a Hunter with an active rolodex. You fit one of these profiles:

• The Expert Network Alumnus (GLG/AlphaSights): You are tired of selling $1,000 phone calls. You want to sell $25k strategic audits.
• The Institutional Sales Rep: You know "Soft Dollars" and have PMs on speed dial.
• The Cap Intro Connector: You want to monetize your network as a Principal, not an employee.

You speak the language:

• You know why a Phase 2 readout is a binary event.
• You understand "Netting Risk" and "Pass-Through Expenses."

The Role

• Your Job: Open the door. Book a "Risk Review" with a PM holding a specific biotech ticker.
• Our Job: Close the deal. Our PhD team proves the risk and handles the paperwork.

The Deal

• Commission: 20-25% of Revenue (Uncapped). Sell a $25k audit → Keep $6,250.
• Equity: Advisory Equity kicker based on revenue milestones.

⛔ DO NOT APPLY IF...

• You want a "Base Salary." This is for those who bet on themselves.
• You have never sold directly to a Hedge Fund.
• You are used to 9-month SaaS sales cycles. We move fast.